AAAAAA
Results:
1-17
|
Results: 17
Authors:
Khurana, R
Citation: R. Khurana, Finding the right CEO: Why boards often make poor choices, MIT SLOAN M, 43(1), 2001, pp. 91
Authors:
Khurana, R
Martin, JF
Zachary, I
Citation: R. Khurana et al., Gene therapy for cardiovascular disease - A case for cautious optimism, HYPERTENSIO, 38(5), 2001, pp. 1210-1216
Authors:
Khurana, R
Uversky, VN
Nielsen, L
Fink, AL
Citation: R. Khurana et al., Is Congo red an amyloid-specific dye?, J BIOL CHEM, 276(25), 2001, pp. 22715-22721
Authors:
Nielsen, L
Khurana, R
Coats, A
Frokjaer, S
Brange, J
Vyas, S
Uversky, VN
Fink, AL
Citation: L. Nielsen et al., Effect of environmental factors on the kinetics of insulin fibril formation: Elucidation of the molecular mechanism, BIOCHEM, 40(20), 2001, pp. 6036-6046
Authors:
Abramov, VM
Vasiliev, AM
Vasilenko, RN
Kulikova, NL
Kosarev, IV
Khlebnikov, VS
Ishchenko, AT
MacIntyre, S
Gillespie, JR
Khurana, R
Korpela, T
Fink, AL
Uversky, VN
Citation: Vm. Abramov et al., Structural and functional similarity between Yersinia pestis capsular protein Caf1 and human interleukin-1 beta, BIOCHEM, 40(20), 2001, pp. 6076-6084
Authors:
Khurana, R
Gillespie, JR
Talapatra, A
Minert, LJ
Ionescu-Zanetti, C
Millett, I
Fink, AL
Citation: R. Khurana et al., Partially folded intermediates as critical precursors of light chain amyloid fibrils and amorphous aggregates, BIOCHEM, 40(12), 2001, pp. 3525-3535
Authors:
Khurana, V
Nehme, O
Khurana, R
Barkin, JS
Citation: V. Khurana et al., Urinary retention secondary to detrusor muscle hypofunction after botulinum toxin injection for achalasia, AM J GASTRO, 96(11), 2001, pp. 3209-3210
Authors:
Fezoui, Y
Hartley, DM
Harper, JD
Khurana, R
Walsh, DM
Condron, MM
Selkoe, DJ
Lansbury, PT
Fink, AL
Teplow, DB
Citation: Y. Fezoui et al., An improved method of preparing the amyloid beta-protein for fibrillogenesis and neurotoxicity experiments, AMYLOID, 7(3), 2000, pp. 166-178
Authors:
Khurana, R
Fink, AL
Citation: R. Khurana et Al. Fink, Do parallel beta-helix proteins have a unique fourier transform infrared spectrum?, BIOPHYS J, 78(2), 2000, pp. 994-1000
Authors:
Uversky, VN
Karnoup, AS
Khurana, R
Segel, DJ
Doniach, S
Fink, AL
Citation: Vn. Uversky et al., Association of partially-folded intermediates of staphylococcal nuclease induces structure and stability, PROTEIN SCI, 8(1), 1999, pp. 161-173
Authors:
Khurana, R
Mahipal, SK
Chauhan, RS
Citation: R. Khurana et al., Effect of pesticides on delayed type hypersensitivity reaction in sheep, I J ANIM SC, 69(11), 1999, pp. 880-881
Authors:
Seshadri, S
Khurana, R
Fink, AL
Citation: S. Seshadri et al., Fourier transform infrared spectroscopy in analysis of protein deposits, METH ENZYM, 309, 1999, pp. 559-576
Authors:
Ionescu-Zanetti, C
Khurana, R
Gillespie, JR
Petrick, JS
Trabachino, LC
Minert, LJ
Carter, SA
Fink, AL
Citation: C. Ionescu-zanetti et al., Monitoring the assembly of Ig light-chain amyloid fibrils by atomic force microscopy, P NAS US, 96(23), 1999, pp. 13175-13179
Authors:
Davis, DP
Khurana, R
Meredith, S
Stevens, FJ
Argon, Y
Citation: Dp. Davis et al., Mapping the major interaction between binding protein and Ig light chains to sites within the variable domain, J IMMUNOL, 163(7), 1999, pp. 3842-3850
Authors:
Lorsch, JW
Khurana, R
Caldwell, P
Kennedy, GD
Michelson, GG
Wendt, H
Zeien, AM
Citation: Jw. Lorsch et al., Changing leaders - The board's role in CEO succession, HARV BUS RE, 77(3), 1999, pp. 96
Authors:
Sahasrabudhe, AV
Solapure, SM
Khurana, R
Suryanarayan, V
Ravishankar, S
deSousa, SM
Das, G
Citation: Av. Sahasrabudhe et al., Production of recombinant human bile salt stimulated lipase and its variant in Pichia pastoris, PROT EX PUR, 14(3), 1998, pp. 425-433
Authors:
Zheng, WX
Khurana, R
Farahmand, S
Wang, YL
Zhang, ZF
Felix, JC
Citation: Wx. Zheng et al., p53 immunostaining as a significant adjunct diagnostic method for uterine surface carcinoma - Precursor of uterine papillary serous carcinoma, AM J SURG P, 22(12), 1998, pp. 1463-1473
Risultati:
1-17
|